Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-05-13 01:19 | 2017-05-10 | DXCM | DEXCOM INC | Balo Andrew K | Officer | SELL | $71.93 | 3,200 | $230,176 | 109,633 |
| 2017-05-12 23:31 | 2017-05-10 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Folkes Robert J. | Officer | SELL | $21.41 | 1,500 | $32,115 | 132,837 |
| 2017-05-12 01:12 | 2017-05-09 | TFX | TELEFLEX INC | Deren John | Officer | OPT+S | $194.07 | 2,246 | $435,892 | 3,989 |
| 2017-05-11 23:04 | 2017-05-09 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $12.29 | 8,000 | $98,300 | 67,825 |
| 2017-05-12 03:03 | 2017-05-09 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Maky | Director | BUY | $20.49 | 53,760 | $1,101,585 | 85,474 |
| 2017-05-12 00:30 | 2017-05-10 | OSUR | ORASURE TECHNOLOGIES INC | Zezzo II Anthony | Officer | OPT+S | $14.70 | 115,000 | $1,690,845 | 145,410 |
| 2017-05-12 00:29 | 2017-05-09 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $15.01 | 209,800 | $3,149,098 | 768,058 |
| 2017-05-12 01:15 | 2017-05-09 | PLSE | PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W | 10% owner | BUY | $21.04 | 43,389 | $912,892 | 3,026,316 |
| 2017-05-11 18:09 | 2017-05-09 | UFPT | UFP TECHNOLOGIES INC | BAILLY R JEFFREY | Director, Officer | SELL | $26.57 | 51,049 | $1,356,571 | 543,675 |
| 2017-05-12 04:05 | 2017-05-11 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | ROCHE KEVIN H | Director | SELL | $21.53 | 30,000 | $645,858 | 151,784 |
| 2017-05-11 02:55 | 2017-05-10 | PLSE | PULSE BIOSCIENCES, INC. | Greenberg Robert J. | Director | OPT+S | $21.12 | 25,000 | $528,110 | 0 |
| 2017-05-11 00:58 | 2017-05-08 | PLSE | PULSE BIOSCIENCES, INC. | Thaure Thierry B. | Director | OPT+S | $22.49 | 15,000 | $337,320 | 0 |
| 2017-05-11 02:11 | 2017-05-08 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $30.98 | 63,622 | $1,971,029 | 3,396,295 |
| 2017-05-10 23:16 | 2017-05-09 | BAX | BAXTER INTERNATIONAL INC | Shapazian Carole J | Director | OPT+S | $55.89 | 3,760 | $210,146 | 12,466 |
| 2017-05-09 23:03 | 2017-05-05 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $11.82 | 8,000 | $94,576 | 75,825 |
| 2017-05-09 23:51 | 2017-05-05 | ATRC | AtriCure, Inc. | Hooven Michael D | Director | OPT+S | $22.08 | 10,000 | $220,800 | 57,049 |
| 2017-05-10 01:53 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | SPAIR RONALD H | Director, Officer | OPT+S | $15.00 | 72,564 | $1,088,656 | 109,066 |
| 2017-05-10 01:50 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | PRINGLE ROGER L | Director | OPT+S | $14.93 | 140,552 | $2,098,863 | 76,452 |
| 2017-05-10 01:49 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | Patrick Charles W | Director | SELL | $14.96 | 10,000 | $149,600 | 56,881 |
| 2017-05-10 01:48 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $15.08 | 361,216 | $5,447,354 | 768,058 |
| 2017-05-10 01:46 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | KUNA MARK L | Officer | OPT+S | $15.11 | 36,413 | $550,018 | 63,491 |
| 2017-05-10 01:45 | 2017-05-05 | OSUR | ORASURE TECHNOLOGIES INC | Celano Michael | Director | SELL | $14.95 | 44,962 | $672,182 | 38,117 |
| 2017-05-10 00:16 | 2017-05-08 | BAX | BAXTER INTERNATIONAL INC | Eyre Brik V | Officer | OPT+S | $55.69 | 130,732 | $7,280,465 | 45,416 |
| 2017-05-09 23:25 | 2017-05-05 | BAX | BAXTER INTERNATIONAL INC | STALLKAMP THOMAS T | Director | OPT+S | $55.76 | 10,698 | $596,489 | 11,273 |
| 2017-05-09 21:36 | 2017-05-05 | UFPT | UFP TECHNOLOGIES INC | BAILLY R JEFFREY | Director, Officer | SELL | $26.62 | 31,359 | $834,886 | 594,724 |
| 2017-05-08 20:15 | 2017-05-04 | MMM | 3M CO | Price Kimberly F | Officer | OPT+S | $198.11 | 3,016 | $597,500 | 6,275 |
| 2017-05-08 21:15 | 2017-05-05 | TTOO | T2 Biosystems, Inc. | Cima Michael J. | Director | BUY | $0.00 | 1,400 | $0 | 184,418 |
| 2017-05-08 17:19 | 2017-05-02 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.43 | 12,800 | $5,454 | 2,457,266 |
| 2017-05-05 23:05 | 2017-05-03 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $11.42 | 8,000 | $91,360 | 83,825 |
| 2017-05-05 23:51 | 2017-05-04 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Coleman Glenn | Officer | SELL | $45.91 | 13,865 | $636,517 | 18,519 |
| 2017-05-05 23:50 | 2017-05-04 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SULLIVAN JAMES M | Director | OPT+S | $45.89 | 15,658 | $718,574 | 54,496 |
| 2017-05-05 18:58 | 2017-05-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $69.55 | 6,365 | $442,679 | 77,896 |
| 2017-05-05 19:38 | 2017-05-04 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $68.75 | 20,000 | $1,374,920 | 301,557 |
| 2017-05-06 03:18 | 2017-05-02 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.43 | 12,800 | $5,454 | 2,458,466 |
| 2017-05-05 23:02 | 2017-05-03 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | OPT+S | $31.14 | 44,340 | $1,380,601 | 46,945 |
| 2017-05-05 23:30 | 2017-05-03 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Rishe Bryan | Officer | SELL | $18.62 | 1,500 | $27,930 | 102,722 |
| 2017-05-04 20:18 | 2017-05-03 | MMM | 3M CO | Lindekugel Jon T | Officer | SELL | $197.22 | 1,300 | $256,388 | 2,238 |
| 2017-05-05 00:29 | 2017-05-02 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $32.35 | 87,342 | $2,825,924 | 3,459,917 |
| 2017-05-05 00:36 | 2017-05-02 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Blake Lynn Larson | Officer | SELL | $19.25 | 2,727 | $52,492 | 53,219 |
| 2017-05-03 23:05 | 2017-05-01 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $11.64 | 8,000 | $93,120 | 91,825 |
| 2017-05-04 00:35 | 2017-05-01 | SYK | STRYKER CORP | Lobo Kevin | Director, Officer | SELL | $135.82 | 9,539 | $1,295,557 | 48,108 |
| 2017-05-04 00:24 | 2017-05-02 | SYK | STRYKER CORP | Scannell Timothy J | Officer | OPT+S | $135.89 | 13,322 | $1,810,381 | 114,623 |
| 2017-05-03 20:25 | 2017-05-01 | RMD | RESMED INC | Sandercock Brett | Officer | SELL | $68.60 | 1,250 | $85,750 | 62,783 |
| 2017-05-02 23:11 | 2017-05-01 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | OPT+S | $26.37 | 15,500 | $408,778 | 101,919 |
| 2017-05-02 23:11 | 2017-05-01 | BSX | BOSTON SCIENTIFIC CORP | Pratt Timothy A. | Officer | SELL | $26.37 | 10,000 | $263,728 | 225,846 |
| 2017-05-02 23:12 | 2017-05-01 | PODD | INSULET CORP | Lemoine David A | Director | SELL | $43.40 | 1,524 | $66,142 | 7,414 |
| 2017-05-02 18:24 | 2017-05-02 | WST | WEST PHARMACEUTICAL SERVICES INC | Malone Daniel | Officer | OPT+S | $93.31 | 4,124 | $384,816 | 29,020 |
| 2017-05-03 03:51 | 2017-04-28 | PLSE | PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W | 10% owner | BUY | $23.88 | 84,348 | $2,013,969 | 35,000 |
| 2017-05-02 03:44 | 2017-04-28 | SYK | STRYKER CORP | COX HOWARD E JR | Director | SELL | $136.11 | 8,615 | $1,172,588 | 554,732 |
| 2017-05-01 23:07 | 2017-04-27 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $11.25 | 8,000 | $89,980 | 99,825 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.